Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02219308 · ClinicalTrials.gov registry record · NA
Pain Control for Intrauterine Device Placement Using Paracervical Block
A NA study of Pain Due to Intrauterine Contraceptive Device, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 67
- Enrollment target
- 2
- Study locations
NCT02219308: Completed NA study of Pain Due to Intrauterine Contraceptive Device, sponsored by University of California, San Diego.
NCT02219308 is a NA study of Pain Due to Intrauterine Contraceptive Device that has completed, run by University of California, San Diego. The registered enrollment target is 67 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02219308, a NA study of Pain Due to Intrauterine Contraceptive Device, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 67 participants
- Enrollment target
- 2
- Study locations
Study Summary
Intrauterine device (IUD) placement can be painful for patients during and after the procedure. Fear of pain from IUD insertion can be a barrier to obtaining this highly effective long acting reversible contraception. Currently there are no proven effective methods for reduction of pain during and after placement of modern IUDs. Paracervical block pain may decrease this placement pain.
Primary Outcome
Distance (mm) from the left of the 100-mm visual analog scale (reflecting magnitude of pain) recorded at time of IUD Placement. Scale range is from 0mm (no pain) to 100mm (worst pain possible). A lower score (less pain) is considered a better outcome.
Conditions Studied
Interventions
- PROCEDURE Paracervical Block (PCB)
- PROCEDURE No Paracervical Block (Sham PCB)
Study Locations (2)
California
- UCSD - San Diego
- Planned Parenthood Mission Bay Parker Center - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2014-10 |
| Est. Completion | 2017-10 |
| Phase | NA |
What the finished NCT02219308 record still lists
NCT02219308 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 67 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Pain Due to Intrauterine Contraceptive Device appearing as the primary indexed condition, and to 2 interventions - of which Paracervical Block (PCB) is the first listed.
NCT02219308 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02219308 about?
NCT02219308 is a clinical study titled "Pain Control for Intrauterine Device Placement Using Paracervical Block". Intrauterine device (IUD) placement can be painful for patients during and after the procedure. Fear of pain from IUD insertion can be a barrier to obtaining this highly effective long acting reversible contraception. Currently there are no proven effective methods for reduction of pain during and a...
What is the current status of trial NCT02219308?
This trial is currently completed. It is a NA study. The enrollment target is 67 participants. The study started on 2014-10. Estimated completion is 2017-10.
What conditions does trial NCT02219308 study?
This clinical trial studies the following conditions: Pain Due to Intrauterine Contraceptive Device.
What interventions are being tested in trial NCT02219308?
The interventions under investigation include: Paracervical Block (PCB) (PROCEDURE), No Paracervical Block (Sham PCB) (PROCEDURE).
Who is sponsoring clinical trial NCT02219308?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02219308 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02219308's enrollment target sits among peer trials
67 1139th of 2000 higher than 862 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03213002 · 67 participants · Phase 1
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
- NCT04115163 · 67 participants · Phase 2
Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer
- NCT04315324 · 67 participants · Phase 1
Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)
- NCT04532424 · 67 participants · NA
Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia